Prospective Analysis of 18F-FDG PET/CT Predictive Value in Patients with Low Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Conservative Surgery
Figure 3
ROC curves for 18F-FDG PET/CT assessment of SUVmax1, SUVmean1, SUVmax2, and SUVmean2 in predicting response to CRT based on Mandard’s TRG (a) and the (y)pTNM (b) criteria.